Laos vs Lebanon: Access to anti-retroviral drugs, female (%)
Laos
71.0%
in 2024
Lebanon
69.0%
in 2024
Laos rank
81st
Lebanon rank
84th
Access to anti-retroviral drugs, female (%) over time
- Laos
- Lebanon
How they compare
Laos currently reports 71.0% against 69.0% in Lebanon, a difference of 2.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Lebanon ahead.
Laos ranks 81st and Lebanon ranks 84th of 141 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Laos | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.7% | 17.0% | 9.3% | Lebanon |
| 2010s | 35.9% | 42.5% | 6.6% | Lebanon |
| 2020s | 61.6% | 66.8% | 5.2% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Laos or Lebanon?
- Laos, at 71.0% against 69.0% in Lebanon as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Laos and Lebanon?
- 2.0%, with Laos ahead.
- How many years of comparable data are there for Laos and Lebanon?
- 24 years are reported by both, from 2000 to 2024.
- How do Laos and Lebanon rank globally for access to anti-retroviral drugs, female?
- Laos ranks 81st and Lebanon ranks 84th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.